These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2. Plotkin SA J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616 [TBL] [Abstract][Full Text] [Related]
4. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. Abu-Raya B; Gantt S; Sadarangani M CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869 [No Abstract] [Full Text] [Related]
5. A vaccine is not too far for COVID-19. Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830 [No Abstract] [Full Text] [Related]
6. COVID-19 vaccines: early success and remaining challenges. Bar-Zeev N; Inglesby T Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290 [No Abstract] [Full Text] [Related]
7. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2. Lodge A Lancet; 2020 Nov; 396(10261):1486. PubMed ID: 33160564 [No Abstract] [Full Text] [Related]
10. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply. Voysey M; Pollard AJ Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565 [No Abstract] [Full Text] [Related]
11. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
12. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2? McPartlin SO; Morrison J; Rohrig A; Weijer C BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564 [No Abstract] [Full Text] [Related]
13. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2. Hanley BP; Keen S; Church G Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623 [No Abstract] [Full Text] [Related]
14. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]
15. The Race to Develop a COVID-19 Vaccine. Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132 [TBL] [Abstract][Full Text] [Related]
16. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts. Mahase E BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065 [No Abstract] [Full Text] [Related]
17. Riding the coronacoaster of uncertainty. The Lancet Infectious Diseases Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202 [No Abstract] [Full Text] [Related]
18. Building Trust to Achieve Confidence in COVID-19 Vaccines. Opel DJ; Salmon DA; Marcuse EK JAMA Netw Open; 2020 Oct; 3(10):e2025672. PubMed ID: 33079194 [No Abstract] [Full Text] [Related]